ITC diversifies tobacco into nicotine and derivatives for US vaping market

Launches new hotel brand "The Storii" which is a collection of boutique lifestyle properties. The brand will grow under ITC's "asset right" model

ITC is diversifying its tobacco business to manufacture and export nicotine and nicotine-derivative products to capture the growing demand for oral and vaping products in the US and EU markets.

The company’s annual report for FY21 mentions that it has set up a wholly-owned subsidiary, IndiVision, and has obtained necessary regulatory approvals for setting up a facility near Mysuru, Karnataka.

The facility, which will manufacture nicotine and nicotine salts, will conform to stringent US and EU pharmacopoeia standards that define purity levels at 99.2 per cent for nicotine meant for pharmaceutical products. ITC will leverage the institutional capabilities of its